Weight-Adjusted Urinary Creatinine Excretion Predicts Transplant Outcomes in Adults With AML in Complete Remission
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Weight-adjusted urinary creatinine excretion predicts transplant outcomes in adult patients with acute myeloid leukemia in complete remission
Leukemia and Lymphoma 2022 Sep 06;[EPub Ahead of Print], A Nagata, Y Otsuka, R Konuma, H Adachi, A Wada, Y Kishida, T Konishi, Y Yamada, R Nagata, Y Noguchi, A Marumo, J Mukae, T Toya, A Igarashi, Y Najima, T Kobayashi, H Sakamaki, K Ohashi, N DokiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.